Who owns Gain Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GANX from SEC Form 13F filings across 50 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 50 institutions disclosed 8.7M shares of Gain Therapeutics, Inc. worth $17.4M — about 20.2% of shares outstanding; the largest disclosed holder is MARSHALL WACE, LLP. Source: SEC Form 13F filings, parsed by EvidInvest.
50
13F holders
$17.4M
value, 2026 filers
20.2%
of shares outstanding (8.7M sh)
13
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GANX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MARSHALL WACE, LLP | 1.9M | $3.9M | 0.0% | 4.5% | +8.7% |
| 2 | Potomac Capital Management, Inc. | 946,400 | $1.9M | 1.3% | 2.2% | -6.2% |
| 3 | GSA CAPITAL PARTNERS LLP | 632,131 | $1.3M | 0.1% | 1.5% | +102.3% |
| 4 | JONES FINANCIAL COMPANIES LLLP | 608,592 | $1.1M | 0.0% | 1.4% | -3.6% |
| 5 | Cambridge Investment Research Advisors, Inc. | 568,645 | $1.2M | 0.0% | 1.3% | 0.0% |
| 6 | DME Capital Management, LP | 566,130 | $1.1M | 0.0% | 1.3% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 480,269 | $974,946 | 0.0% | 1.1% | +20.1% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 453,501 | $921,372 | 0.0% | 1.1% | +1.4% |
| 9 | BlackRock, Inc. | 274,957 | $558,163 | 0.0% | 0.6% | +22.2% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 231,534 | $470,014 | 0.0% | 0.5% | +0.7% |
| 11 | UBS Group AG | 215,012 | $436,475 | 0.0% | 0.5% | -2.5% |
| 12 | Stratos Wealth Partners, LTD. | 200,000 | $406,000 | 0.0% | 0.5% | +52.0% |
| 13 | Cresset Asset Management, LLC | 160,000 | $324,800 | 0.0% | 0.4% | 0.0% |
| 14 | STATE STREET CORP | 157,537 | $319,800 | 0.0% | 0.4% | 0.0% |
| 15 | CITADEL ADVISORS LLC | 154,524 | $313,684 | 0.0% | 0.4% | +520.6% |
| 16 | Squarepoint Ops LLCNEW | 136,359 | $276,809 | 0.0% | 0.3% | new |
| 17 | MORGAN STANLEY | 125,972 | $255,723 | 0.0% | 0.3% | -9.8% |
| 18 | LPL Financial LLC | 117,251 | $238,020 | 0.0% | 0.3% | +12.5% |
| 19 | NORTHERN TRUST CORP | 97,013 | $196,936 | 0.0% | 0.2% | -14.9% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 78,206 | $158,758 | 0.0% | 0.2% | -81.9% |
| 21 | COMMONWEALTH EQUITY SERVICES, LLC | 58,456 | $118,670 | 0.0% | 0.1% | +96.8% |
| 22 | JANE STREET GROUP, LLC | 55,628 | $112,925 | 0.0% | 0.1% | -74.4% |
| 23 | XTX Topco LtdNEW | 55,294 | $112,247 | 0.0% | 0.1% | new |
| 24 | PRELUDE CAPITAL MANAGEMENT, LLC | 35,820 | $72,715 | 0.0% | 0.1% | 0.0% |
| 25 | BENEDICT FINANCIAL ADVISORS INC | 35,000 | $71,050 | 0.0% | 0.1% | +125.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.